Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome
- PMID: 29633639
- PMCID: PMC6366941
- DOI: 10.3920/BM2017.0059
Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome
Abstract
Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with symptoms and/or reflect alterations in gastrointestinal permeability and gut microbiota in an IBS population, we correlated stool and urine TFF3 levels with IBS symptoms, intestinal permeability, stool microbial diversity and relative abundance of predominant bacterial families and genera. We also tested the relationship of stool TFF3 to urine TFF3, and compared results based on hormone contraception use. Samples were obtained from 93 females meeting Rome III IBS criteria and completing 4-week symptom diaries. TFF3 levels were measured by ELISA. Permeability was assessed with the urine lactulose/mannitol (L/M) ratio. Stool microbiota was assessed using 16S rRNA. Stool TFF3, but not urine TFF3, was associated positively with diarrhoea and loose stool consistency. Higher stool TFF3 was also associated with lower L/M ratio and microbial diversity. Of the 20 most abundant bacterial families Mogibacteriaceae and Christensenellaceae were inversely related to stool TFF3, with only Christensenellaceae remaining significant after multiple comparison adjustment. There were no significant relationships between stool or urine TFF3 levels and other symptoms, nor between stool and urine levels. In premenopausal females, urine TFF3 levels were higher in those reporting hormone contraception. Collectively these results suggest that higher stool TFF3 levels are associated with IBS symptoms (loose/diarrhoeal stools), lower gut permeability, and altered stool bacteria composition (decreased diversity and decreased Christensenellaceae), which further suggests that TFF3 may be an important marker of host-bacteria interaction.
Keywords: Christensenellaceae; anti-microbial peptide; diarrhoea; hormone contraception.
Figures
References
-
- Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P and Versalovic J, 2013. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 27: 1012–1022. - PMC - PubMed
-
- Aronesty E, 2011. Command-line tools for processing biological sequencing data Available at: https://github.com/ExpressionAnalysis/ea-utils.
-
- Beck PL, Ihara E, Hirota SA, MacDonald JA, Meng D, Nanthakumar NN, Podolsky DK and Xavier RJ, 2010. Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3. American journal of physiology. Gastrointestinal and liver physiology 299: G43–53. - PMC - PubMed
-
- Bennet SM, Polster A, Tornblom H, Isaksson S, Capronnier S, Tessier A, Le Neve B, Simren M and Ohman L, 2016. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome. The American journal of gastroenterology - PubMed
-
- Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, Capri M, Brigidi P and Candela M, 2016. Gut Microbiota and Extreme Longevity. Current biology : CB 26: 1480–1485. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
